Conditions Experimental Genital Herpes Drug Shows Promise by explainingmedicine June 22, 2016 Drug lowered viral activity, recurrence of symptoms in study patients Experimental Genital Herpes Drug Shows Promise was last modified: June 22nd, 2016 by explainingmedicine Related 0 comment 0 Facebook Twitter Google + Pinterest explainingmedicine previous post Ryzodeg 70/30 (see Insulin Aspart/Insulin Degludec (By injection)) next post Frozen Peas and Mixed Vegetables Recalled Related Articles Aquatensen (see Methyclothiazide (Oral route)) June 17, 2016 Femtrace (see Estrogen (Oral route, Parenteral route, Topical application route, Transdermal route)) June 20, 2016 Norphyl (see Aminophylline (Oral route)) June 21, 2016 Rite Aid Antifungal (see Terbinafine (On the skin)) June 21, 2016 Cyclocort (see Amcinonide (Topical application route)) June 18, 2016 Pms-Mometasone (see Mometasone (On the skin)) June 21, 2016 Tanzeum (see Albiglutide (Subcutaneous route)) June 16, 2016 Azulfidine (see Salicylate (Oral route, Rectal route)) June 17, 2016 Carac (see Fluorouracil (On the skin)) June 18, 2016 Endometrial Cancer: Symptoms June 13, 2016